A 3-week-old male infant is brought to the emergency department by his mother who reports that he has been feeding poorly and has been irritable for the past 12 hours. The mother also notes that he has been breathing rapidly and appears pale. She denies any fever, cough, or vomiting. The infant was born at term via normal vaginal delivery with no complications and has been feeding well until today. There is no known family history of heart disease or sudden death.
Examination: Vital signs: HR 280 bpm (regular), RR 60/min, BP 85/50 mm Hg, SpO2 96% on room air. The infant is pale, irritable, and has mild tachypnea. Cardiovascular examination reveals a regular, rapid heart rate with no audible murmurs. The liver edge is palpable 2 cm below the right costal margin. There is no peripheral edema or cyanosis.
ECG (obtained in ED):
Figure: ECG shows narrow QRS tachycardia (QRS <0.08 sec) at a rate of 280 bpm. No visible P waves (retrograde or buried in QRS). Regular RR intervals.
Task for the candidate: You are the pediatric cardiologist. Evaluate this infant, interpret the ECG, differentiate SVT from sinus tachycardia, discuss the mechanisms of SVT (AVRT, AVNRT, atrial flutter, atrial ectopic tachycardia), formulate an acute management plan (vagal maneuvers, adenosine, cardioversion), and provide counseling about long-term management (beta-blockers, digoxin, ablation) and prognosis (spontaneous resolution by 12-18 months).
π‘ Examiner instruction (interactive): This is a case of Supraventricular Tachycardia (SVT) β the most common arrhythmia in infants. The candidate must recognize the ECG pattern (narrow QRS tachycardia, rate >220 bpm in infants, no visible P waves), differentiate SVT from sinus tachycardia (abrupt onset, fixed rate, abnormal P axis), and understand that AVRT (accessory pathway) is the most common mechanism in infants. Acute management includes vagal maneuvers (ice to face), adenosine (0.1-0.2 mg/kg IV push), and synchronized cardioversion if unstable. Chronic management includes beta-blockers (propranolol) or digoxin (if no WPW). The candidate should also discuss that many infants outgrow SVT by 12-18 months and that catheter ablation is reserved for older children or refractory cases. The candidate must recognize signs of heart failure (hepatomegaly) and that unstable patients require immediate cardioversion.
π Examiner Questions (interactive) β Click to reveal model answers
β Q1 (Examiner): βDescribe the ECG findings in this infant. How do you distinguish SVT from sinus tachycardia?β
β Candidate's answer:
β’ ECG findings in SVT:
- Narrow QRS complex (<0.08 seconds in infants, <0.09 seconds in older children).
- Regular tachycardia with rate >220 bpm in infants (>180 bpm in children).
- No visible P waves β P waves are often buried in the QRS complex (AVNRT) or retrograde (AVRT).
- Fixed RR intervals β no variation.
β’ Distinguishing SVT from sinus tachycardia:
- Sinus tachycardia: Gradual onset and offset, rate varies with activity/emotion/fever, normal P wave axis (positive in I, II, aVF), PR interval normal.
- SVT: Abrupt onset and offset, rate is fixed and does not vary with activity, P waves are abnormal (absent, retrograde, or buried), PR interval may be prolonged or absent.
- Vagal maneuvers: Adenosine terminates SVT but only slows sinus tachycardia.
- ECG in sinus rhythm: Look for delta wave (WPW), short PR, or other clues to mechanism.
β Q2 (Examiner): βWhat are the mechanisms of SVT in children? Which is most common in infants?β
β Candidate's answer:
β’ Mechanisms of SVT in children (Nelson Ch 484.3):
1οΈβ£ AVRT (Atrioventricular reentry tachycardia) β most common in infants (<1 year).
- Orthodromic AVRT: Antegrade conduction down the AV node, retrograde up the accessory pathway (narrow QRS). Associated with WPW (delta wave in sinus rhythm).
- Antidromic AVRT: Antegrade down accessory pathway, retrograde up AV node (wide QRS β rare).
2οΈβ£ AVNRT (Atrioventricular nodal reentry tachycardia) β common in adolescents (dual AV node pathways).
3οΈβ£ Atrial flutter (intra-atrial reentry) β common after congenital heart disease repair (Fontan, Mustard).
4οΈβ£ Atrial ectopic tachycardia (automatic) β incessant, may cause cardiomyopathy.
5οΈβ£ Junctional ectopic tachycardia (JET) β post-operative (tetralogy of Fallot).
β’ Most common mechanism in infants:AVRT (accessory pathway) β accounts for ~90% of SVT in infants <1 year. Often associated with WPW (delta wave in sinus rhythm).
β Q3 (Examiner): βThis infant is hemodynamically stable (BP 85/50, no signs of shock). What is your acute management?β
β Candidate's answer:
β’ Step 1: Vagal maneuvers (while preparing IV access and monitoring):
- Ice to face: Cover the infant's face (eyes, nose, mouth) with a small bag of ice water for 15-30 seconds β effective in infants (triggers diving reflex).
- Valsalva: Not effective in infants.
- Carotid sinus massage and ocular pressure are contraindicated (dangerous in infants).
β’ Step 2: Adenosine (if vagal maneuvers fail):
- First dose: 0.1 mg/kg rapid IV push (max 6 mg) β followed by a saline flush (2-3 mL).
- Second dose: 0.2 mg/kg rapid IV push (max 12 mg) if no effect.
- Adenosine terminates AVRT by blocking the AV node (anterograde limb).
- Side effects: transient asystole, flushing, chest pain, bronchospasm (rare).
β’ Step 3: Alternative medications (if adenosine fails):
- Esmolol (IV beta-blocker): 500 mcg/kg over 1-2 min (contraindicated in asthma).
- Procainamide (IV class Ia): 15 mg/kg over 30-60 min β useful for refractory SVT or atrial flutter.
- Amiodarone (IV class III): 5 mg/kg β reserve for unstable/refractory cases.
- Avoid verapamil in infants <1 year β risk of cardiovascular collapse.
β’ If unstable (hypotension, poor perfusion, altered consciousness):
- Synchronized cardioversion β 0.5-1 J/kg, increase to 2 J/kg if needed.
β Q4 (Examiner): βHow does adenosine work? What are its side effects and contraindications?β
β Candidate's answer:
β’ Mechanism: Adenosine is a purine nucleoside that binds to A1 receptors in the AV node, causing transient AV block (slows conduction and increases refractoriness). It terminates reentry circuits that use the AV node as the anterograde limb (AVRT, AVNRT).
β’ Dosing:
- First dose: 0.1 mg/kg rapid IV push (max 6 mg).
- Second dose: 0.2 mg/kg rapid IV push (max 12 mg).
- Administer via a central or large peripheral vein with a rapid flush (2-3 mL of saline).
β’ Side effects (transient):
- Flushing (most common).
- Bronchospasm (contraindicated in asthma).
- Chest pain, dyspnea.
- Transient asystole (few seconds β usually resolves spontaneously).
- Headache, nausea.
β’ Contraindications:
- Asthma (relative) β risk of bronchospasm.
- Second- or third-degree heart block (unless pacemaker).
- Sick sinus syndrome.
- Do not use in wide complex tachycardia (may cause VF).
β’ Half-life: <10 seconds β very short action.
β Q5 (Examiner): βIf this infant was hypotensive and poorly perfused, what would you do?β
β Candidate's answer:
β’ Unstable SVT (hypotension, shock, altered consciousness):
- Immediate synchronized cardioversion β 0.5-1 J/kg, increase to 2 J/kg if unsuccessful.
- Sedation if time permits (midazolam, ketamine).
- If IV access is available: Adenosine can be administered while preparing for cardioversion.
- Do not delay cardioversion for IV access.
β’ Post-cardioversion: Obtain ECG in sinus rhythm, monitor for recurrence, and start oral propranolol or digoxin.
β’ If the patient is pulseless: Follow PALS algorithm β CPR, defibrillation (2 J/kg β 4 J/kg), epinephrine, amiodarone.
β Q6 (Examiner): βThis infant was successfully converted with adenosine. What is your long-term management plan?β
β Candidate's answer:
β’ Long-term management of infant SVT:
1οΈβ£ If no WPW (no delta wave in sinus rhythm):
- Propranolol (1-2 mg/kg/day, divided TID) or digoxin (10-15 mcg/kg loading, then 5-10 mcg/kg/day) β both effective.
2οΈβ£ If WPW (delta wave present):
- Propranolol or flecainide β first-line.
- Digoxin and verapamil are contraindicated in WPW (risk of preexcited AF β VF).
3οΈβ£ Echocardiogram: To exclude structural heart disease (especially if WPW).
4οΈβ£ Follow-up: Monitor for recurrence. Many infants will outgrow SVT by 12-18 months.
5οΈβ£ Medication weaning: After 6-12 months of being event-free, medication can be weaned (usually after 1 year of age).
6οΈβ£ Catheter ablation: Reserved for refractory cases, or older children (>15 kg) with symptomatic WPW.
β’ Parent education: Teach parents to recognize signs of SVT (poor feeding, pallor, irritability) and when to seek emergency care.
β Q7 (Examiner): βWhat is Wolff-Parkinson-White (WPW) syndrome? Why is digoxin contraindicated in WPW?β
β Candidate's answer:
β’ WPW syndrome: A form of preexcitation caused by an accessory pathway (Kent bundle) connecting the atria to the ventricles. Characterized by:
- Short PR interval (for age).
- Delta wave (slurred upstroke of the QRS).
- Wide QRS complex (due to fusion of AV node and accessory pathway conduction).
β’ Risk: SVT (orthodromic AVRT) and atrial fibrillation with rapid conduction over the accessory pathway β VF β sudden death.
β’ Why digoxin is contraindicated in WPW:
- Digoxin shortens the refractory period of the accessory pathway and slows conduction through the AV node β in atrial fibrillation, the accessory pathway can conduct rapidly (without AV node delay) β rapid ventricular rate β ventricular fibrillation and sudden death.
β’ Other contraindicated drugs: Verapamil (calcium channel blockers) β same mechanism.
β’ Safe medications: Beta-blockers (propranolol), flecainide, amiodarone, sotalol.
β’ Definitive treatment: Catheter ablation (curative, success >95%).
β Q8 (Examiner): βA 16-year-old with repaired tetralogy of Fallot presents with palpitations. ECG shows sawtooth flutter waves at 300 bpm. What is the arrhythmia and how do you treat it?β
β Candidate's answer:
β’ Diagnosis:Atrial flutter (intra-atrial reentry) β common after atrial surgery (Fontan, Mustard, ASD closure, TOF repair).
β’ ECG features: Sawtooth flutter waves (II, III, aVF), atrial rate 250-400 bpm, variable AV block (2:1, 3:1, 4:1).
β’ Acute management (stable):
- Anticoagulation: If duration >48 hours, transesophageal echo (TEE) to rule out thrombus, or anticoagulate for 3-4 weeks before cardioversion.
- Synchronized cardioversion: 0.5-1 J/kg (first-line for acute conversion).
- If unstable: Immediate synchronized cardioversion.
- Pharmacologic: Amiodarone, ibutilide, or procainamide.
β’ Long-term management:
- Catheter ablation: Of the flutter circuit (cavotricuspid isthmus-dependent or intra-atrial) β curative.
- Anticoagulation: Lifelong if high-risk (Fontan, CHD with residual lesions).
- Rate control: Beta-blockers or digoxin (if no WPW).
β Q9 (Examiner): βAn infant with incessant tachycardia develops cardiomyopathy. The mechanism is atrial ectopic tachycardia. What is the treatment?β
β Candidate's answer:
β’ Atrial ectopic tachycardia (AET): An automatic (non-reentrant) tachycardia originating from an ectopic atrial focus. It is often incessant and can cause tachycardia-induced cardiomyopathy if left untreated.
β’ ECG: Abnormal P wave morphology (axis), rate varies (warm-up/cool-down), no abrupt onset/offset.
β’ Treatment:
- Class Ic antiarrhythmics:Flecainide (1-3 mg/kg/day) β first-line.
- Class III: Amiodarone or sotalol (second-line).
- Beta-blockers: May be used as adjunctive therapy.
- Catheter ablation: Difficult in infants, but possible if refractory and weight >15 kg.
- If cardiomyopathy develops: Heart failure management (diuretics, ACE inhibitors). The cardiomyopathy often reverses after successful tachycardia control.
β Q10 (Examiner): βA 5-year-old post-VSD repair develops narrow QRS tachycardia with AV dissociation. What is the diagnosis and treatment?β
β Candidate's answer:
β’ Diagnosis:Junctional Ectopic Tachycardia (JET) β common post-operative arrhythmia after congenital heart surgery (tetralogy of Fallot, VSD).
β’ ECG: Narrow QRS tachycardia (rate 180-250 bpm) with AV dissociation (P waves independent of QRS).
β’ Management:
- Cooling the patient β decrease core temperature to 34-35Β°C (reduces automaticity).
- Amiodarone (IV 5 mg/kg, then infusion).
- Dexmedetomidine β sedative that reduces sympathetic tone.
- Procainamide β alternative.
- Avoid catecholamines (may worsen JET).
- If refractory: Atrial overdrive pacing or ECMO.
β’ Prognosis: Usually resolves within 24-48 hours with treatment.
β Q11 (Examiner): βThis infant's mother has a history of palpitations. What is the inheritance of WPW? Should family members be screened?β
β Candidate's answer:
β’ Inheritance: Most WPW cases are sporadic, but familial WPW exists and is inherited in an autosomal dominant pattern with variable penetrance. Mutations in PRKAG2 and MYH6 have been associated with familial WPW.
β’ Family screening:
- First-degree relatives of a patient with WPW should undergo ECG screening (especially if the patient has a family history of WPW or sudden death).
- If an asymptomatic relative has WPW on ECG, further evaluation (Holter, EP study) is recommended if they participate in competitive sports or have symptoms.
- Asymptomatic family members with no ECG findings do not need further screening unless they develop symptoms.
β’ Genetic testing: Not routinely performed unless there is a strong family history of WPW or PRKAG2 syndrome (WPW + HCM + conduction disease).
β Q12 (Examiner): βA 14-year-old with WPW and recurrent SVT wants to play competitive soccer. What is the recommendation?β
β Candidate's answer:
β’ AHA/ACC guidelines for WPW and sports:
- Symptomatic WPW patients should undergo catheter ablation before participating in competitive sports. After successful ablation, patients can return to sports after 3-6 months (if no arrhythmia recurrence).
- Asymptomatic WPW patients: Can participate in sports if they undergo an invasive EP study that demonstrates a low-risk accessory pathway (SPERRI >250 ms, AP ERP >250 ms, no inducible AF).
- High-risk activities: Competitive sports (basketball, soccer, football, swimming) are high-risk and should be avoided until risk stratification or ablation is completed.
β’ Recommendation for this patient: Since he has symptoms (palpitations, near-syncope), he should not participate in competitive sports until he undergoes EP study and ablation. After successful ablation, he can return to sports.
β Q13 (Examiner): βA 2-week-old with Ebstein anomaly and SVT. What is the association between Ebstein anomaly and WPW?β
β Candidate's answer:
β’ Ebstein anomaly is a congenital heart defect characterized by downward displacement of the tricuspid valve into the right ventricle.
β’ Association with WPW: Up to 30% of patients with Ebstein anomaly have WPW β due to the presence of multiple accessory pathways (often right-sided).
β’ Clinical implications:
- High risk of recurrent SVT and preexcited atrial fibrillation.
- Risk of sudden cardiac death is higher than in isolated WPW.
β’ Management:
- Catheter ablation is the treatment of choice β but may be more complex due to multiple pathways.
- Medical therapy: Beta-blockers, flecainide.
- Avoid digoxin and verapamil.
- ICD placement may be needed for high-risk patients.
- Transition: Lifelong follow-up with a cardiologist experienced in adult congenital heart disease.
β Q14 (Examiner): βThe parents are very anxious about their infant's SVT. How will you counsel them?β
β Candidate's structured answer:
β’ βYour baby has a condition called Supraventricular Tachycardia β a fast heart rhythm that starts in the upper chambers of the heart. This causes the heart to beat too fast, which can make your baby feed poorly and feel tired.β
β’ βThe good news is that this is a very treatable condition. We have stopped the fast rhythm today using a medication called adenosine. For the future, we will start a daily medication (propranolol) to prevent it from happening again.β
β’ βMost babies outgrow this by 12-18 months of age as their hearts mature. In most cases, this does not cause any long-term heart problems.β
β’ βYou will need to give the medication regularly and watch for signs of a fast heartbeat (pale, irritable, poor feeding). If you think it's happening again, bring your baby to the nearest emergency department.β
β’ βWe will see your baby regularly to monitor growth and adjust the medication. Your baby will grow up to be a healthy child.β
π£οΈ Examiner's probing / high-yield points (Supraventricular Tachycardia):
β’ "What is the first-line drug for acute SVT in a stable infant?" β Adenosine 0.1 mg/kg IV push.
β’ "What vagal maneuver is used in infants?" β Ice to face (15-30 seconds).
β’ "What is the most common mechanism of SVT in infants?" β AVRT (accessory pathway).
β’ "Which medications are contraindicated in WPW?" β Digoxin and verapamil (risk of VF).
β’ "What is the treatment for unstable SVT?" β Synchronized cardioversion 0.5-1 J/kg.
β’ "What is the first-line chronic medication for infant SVT?" β Propranolol (or digoxin if no WPW).
β’ "What is the prognosis for infant SVT?" β Most outgrow by 12-18 months.
β’ "What is the definitive treatment for WPW?" β Catheter ablation (success >95%).
β’ "What is the ECG hallmark of WPW?" β Short PR, delta wave, wide QRS.
π Supraventricular Tachycardia β Core Revision for TOACS
β‘ Definition Narrow QRS tachycardia (QRS <0.09 sec) originating above His bundle. Rate >220 bpm in infants, >180 bpm in children. Most common arrhythmia in infants.
π Mechanisms AVRT (accessory pathway) β most common in infants. AVNRT (dual AV node) β common in adolescents. Atrial flutter β post-op CHD. Atrial ectopic tachycardia β incessant, cardiomyopathy.
π Acute Management Vagal maneuvers (ice to face in infants). Adenosine 0.1-0.2 mg/kg IV push. Unstable β synchronized cardioversion 0.5-1 J/kg. Avoid verapamil in infants.
π Chronic Management Beta-blockers (propranolol) or digoxin (if no WPW). Avoid digoxin/verapamil in WPW. Infant SVT often resolves by 12-18 months. Ablation for refractory/older children.
β οΈ WPW Syndrome ECG: short PR, delta wave, wide QRS. Risk of preexcited AF β VF. Avoid digoxin, verapamil. Ablation for symptomatic or high-risk patients.
β High-yield pearls for TOACS (Supraventricular Tachycardia):
β’ First-line acute: Adenosine 0.1 mg/kg IV push.
β’ Infant vagal maneuver: Ice to face.
β’ Most common SVT in infants: AVRT (accessory pathway).
β’ Avoid digoxin and verapamil in WPW.
β’ Unstable: Synchronized cardioversion (0.5-1 J/kg).
β’ Chronic infant: Propranolol (or digoxin if no WPW).
β’ Most infants outgrow SVT by 12-18 months.
β’ WPW ECG: Short PR + Delta wave + Wide QRS.
β’ Ablation is curative for WPW (success >95%).
π£οΈ Candidate's role-play & examiner feedback
π¬ To the candidate (roleβplay): You will be asked the 14 questions from the Examiner Q&A tab. This station tests knowledge of Supraventricular Tachycardia β ECG interpretation (narrow QRS, no P waves), mechanisms (AVRT, AVNRT, atrial flutter), acute management (adenosine, cardioversion, vagal maneuvers), chronic management (beta-blockers, digoxin, ablation), and WPW syndrome (digoxin/verapamil contraindicated). Provide empathetic counseling to parents about prognosis (most outgrow by 12-18 months) and lifestyle modifications.
β Prescribes chronic therapy: propranolol (or digoxin if no WPW)
β States that digoxin/verapamil are contraindicated in WPW
β Discusses that most infants outgrow SVT by 12-18 months
β Counsels parents about medication adherence, warning signs, and prognosis
π Key references: Nelson Textbook of Pediatrics 22e (Chapter 484.3 β Supraventricular Tachycardia), AHA/ACC/HRS Guidelines, Pediatric EP Society recommendations.